Marketable Securities, Current in USD of Celldex Therapeutics, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Celldex Therapeutics, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2010 to Q3 2025.
  • Celldex Therapeutics, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $547M, a 24% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $547M -$172M -24% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $607M -$152M -20% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $656M -$52.6M -7.42% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $697M +$308M +79.3% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $720M +$505M +236% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $760M +$535M +238% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $709M +$485M +216% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $389M +$113M +41.1% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $214M -$90.7M -29.7% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $224M -$104M -31.7% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $224M -$131M -36.9% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $276M -$93.6M -25.4% 31 Dec 2022 10-K 26 Feb 2024
Q3 2022 $305M -$46M -13.1% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $328M +$208M +172% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $355M +$248M +233% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $369M +$219M +145% 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $351M +$169M +93.4% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $121M -$18.3M -13.2% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $107M +$75.8M +244% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $151M +$97.4M +183% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $181M +$125M +222% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $139M +$77.3M +125% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $31M 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $53.2M -$16.6M -23.8% 31 Dec 2019 10-K 29 Mar 2021
Q3 2019 $56.3M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $61.6M 30 Jun 2019 10-Q 07 Aug 2019
Q4 2018 $69.7M 31 Dec 2018 10-K 26 Mar 2020
Q1 2012 $69.4M 31 Mar 2012 10-Q 04 May 2012
Q4 2011 $41.4M +$1.6M +4.02% 31 Dec 2011 10-Q 04 May 2012
Q3 2011 $49.7M 30 Sep 2011 10-Q 03 Nov 2011
Q2 2011 $60.4M 30 Jun 2011 10-Q 04 Aug 2011
Q4 2010 $39.8M 31 Dec 2010 10-K 08 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.